Third Dose of the BNT162b2 Vaccine Results in Sustained High Levels of Neutralizing Antibodies Against SARS-CoV-2 at 6 Months Following Vaccination in Healthy Individuals

Affiliations

• ¹ Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Greece.
• ² Section of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, Greece.
• ³ Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Greece.